RxDoctor Payments Data

Natasha Dougherty

Critical Care Medicine · Lexington, KYNPI 1851586879

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,236, 2.5 times the $493 reported in 2021. Among critical care medicine clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,275in general payments, 2019–2025

Across 171 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shionogi Inc$817
  • Gilead$570
  • Merck$491
  • La Jolla Pharmaceutical Company$453
  • Viiv Healthcare Company$431
  • Astellas Pharma US Inc$384
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$4,19998%
  • Education$762%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,275 in reported general payments places this provider in the 90th percentile of 60 critical care medicine providers in Kentucky.

See all critical care medicine providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
GenvoyaElviteg/Cob/Emtri/Tenof Alafen18$68,503
BiktarvyBictegrav/Emtricit/Tenofov Ala14$54,841
Methenamine Hippurate19$1,739
Doxycycline Hyclate57$1,284
CefuroximeCefuroxime Axetil11$622
Amoxicillin28$401
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$360
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadGenvoya, Biktarvy$570$123,34432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 60 critical care medicine providers in Kentucky.

Other critical care medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →